Literature DB >> 21562994

Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Jeanie C Yoon1, Paul K Crane, Paul S Ciechanowski, Robert D Harrington, Mari M Kitahata, Heidi M Crane.   

Abstract

Studies of depression and hepatitis C virus (HCV) infection in HIV-infected patients have been contradictory and often not addressed key differences between HCV-infected and uninfected individuals including substance use. This cross-sectional observational study from the University of Washington HIV cohort examined associations between HCV, symptoms, and depression in HIV-infected patients in routine clinical care. Patients completed instruments measuring depression, symptoms, and substance use. We generated depression severity scores and used linear regression to examine the relationship with HCV accounting for demographic and clinical characteristics. We conducted sensitivity analyses in which we removed depression somatic symptom items (e.g., fatigue) from depression scores, and sensitivity analyses in which we also adjusted for nondepression somatic symptom items to examine the role of somatic and nonsomatic symptoms in the association between depression and HCV. Of 764 HIV-infected patients, 160 (21%) were HCV-infected. In adjusted analysis, HCV-infected patients had worse depression severity (p =0.01) even after adjusting for differences in substance use. HCV remained associated with depression severity in secondary analyses that omitted the depression somatic patient health questionnaire-9 (PHQ-9) items (p=0.01). However, when nondepression somatic symptoms were included as covariates in multivariate analyses, HCV was no longer associated with depression (p=0.09).

Entities:  

Mesh:

Year:  2011        PMID: 21562994      PMCID: PMC3534977          DOI: 10.1080/09540121.2011.555739

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  59 in total

1.  Fatigue and psychological disorders in chronic hepatitis C.

Authors:  Jennifer McDonald; Jayasuriya Jayasuriya; Patricia Bindley; Craig Gonsalvez; Sonja Gluseska
Journal:  J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 4.029

2.  Fatigue in patients with chronic hepatitis C.

Authors:  T Poynard; P Cacoub; V Ratziu; R P Myers; M H Dezailles; A Mercadier; P Ghillani; F Charlotte; J C Piette; J Moussalli
Journal:  J Viral Hepat       Date:  2002-07       Impact factor: 3.728

3.  Development and validation of a self-completed HIV symptom index.

Authors:  A C Justice; W Holmes; A L Gifford; L Rabeneck; R Zackin; G Sinclair; S Weissman; J Neidig; C Marcus; M Chesney; S E Cohn; A W Wu
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

4.  Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test.

Authors:  Antoni Gual; Lidia Segura; Montserrat Contel; Nick Heather; Joan Colom
Journal:  Alcohol Alcohol       Date:  2002 Nov-Dec       Impact factor: 2.826

5.  Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immunodeficiency virus infections in intravenous drug users.

Authors:  Luigi Grassi; James Satriano; Alessia Serra; Bruno Biancosino; Spyridon Zotos; Laura Sighinolfi; Florio Ghinelli
Journal:  Psychother Psychosom       Date:  2002 Nov-Dec       Impact factor: 17.659

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  Psychiatric disorders among veterans with hepatitis C infection.

Authors:  Hashem B el-Serag; Mark Kunik; Peter Richardson; Linda Rabeneck
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

8.  Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.

Authors:  A W Wu; K L Jacobson; K D Frick; R Clark; D A Revicki; K A Freedberg; J Scott-Lennox; J Feinberg
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

9.  Hepatitis C and progression of HIV disease.

Authors:  Mark S Sulkowski; Richard D Moore; Shruti H Mehta; Richard E Chaisson; David L Thomas
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

10.  The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.

Authors: 
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

View more
  7 in total

1.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

2.  Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation.

Authors:  Jeffrey J Weiss; Sarah Prieto; Norbert Bräu; Douglas T Dieterich; Sue M Marcus; Alicia Stivala; Jack M Gorman
Journal:  Int J Psychiatry Med       Date:  2018-01-03       Impact factor: 1.210

3.  Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.

Authors:  Marcia D McNutt; Shuling Liu; Amita Manatunga; Erica B Royster; Charles L Raison; Bobbi J Woolwine; Marina F Demetrashvili; Andrew H Miller; Dominique L Musselman
Journal:  Neuropsychopharmacology       Date:  2012-02-22       Impact factor: 7.853

4.  Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection.

Authors:  Marco Pereira; Renata Fialho
Journal:  J Behav Med       Date:  2016-08-09

5.  Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.

Authors:  Perrine Roux; Caroline Lions; Julien Cohen; Maria Winnock; Dominique Salmon-Céron; Firouze Bani-Sadr; Philippe Sogni; Bruno Spire; François Dabis; Maria Patrizia Carrieri
Journal:  Antivir Ther       Date:  2013-10-28

6.  Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.

Authors:  Edward R Cachay; David L Wyles; Miguel Goicoechea; Francesca J Torriani; Craig Ballard; Bradford Colwell; Robert G Gish; William C Mathews
Journal:  AIDS Res Ther       Date:  2011-08-10       Impact factor: 2.250

7.  Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment.

Authors:  Lydia Shuk Yee Tang; Jack Masur; Zayani Sims; Amy Nelson; Anu Osinusi; Anita Kohli; Sarah Kattakuzhy; Michael Polis; Shyam Kottilil
Journal:  World J Hepatol       Date:  2016-11-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.